1. Home
  2. VIR vs DAKT Comparison

VIR vs DAKT Comparison

Compare VIR & DAKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIR
  • DAKT
  • Stock Information
  • Founded
  • VIR 2016
  • DAKT 1968
  • Country
  • VIR United States
  • DAKT United States
  • Employees
  • VIR N/A
  • DAKT N/A
  • Industry
  • VIR Biotechnology: Pharmaceutical Preparations
  • DAKT Office Equipment/Supplies/Services
  • Sector
  • VIR Health Care
  • DAKT Industrials
  • Exchange
  • VIR Nasdaq
  • DAKT Nasdaq
  • Market Cap
  • VIR 844.9M
  • DAKT 711.0M
  • IPO Year
  • VIR 2019
  • DAKT 1994
  • Fundamental
  • Price
  • VIR $5.23
  • DAKT $14.23
  • Analyst Decision
  • VIR Strong Buy
  • DAKT Strong Buy
  • Analyst Count
  • VIR 7
  • DAKT 1
  • Target Price
  • VIR $32.86
  • DAKT $26.00
  • AVG Volume (30 Days)
  • VIR 1.4M
  • DAKT 625.1K
  • Earning Date
  • VIR 07-31-2025
  • DAKT 06-25-2025
  • Dividend Yield
  • VIR N/A
  • DAKT N/A
  • EPS Growth
  • VIR N/A
  • DAKT N/A
  • EPS
  • VIR N/A
  • DAKT 0.04
  • Revenue
  • VIR $20,861,000.00
  • DAKT $799,806,000.00
  • Revenue This Year
  • VIR N/A
  • DAKT N/A
  • Revenue Next Year
  • VIR N/A
  • DAKT $4.86
  • P/E Ratio
  • VIR N/A
  • DAKT $389.68
  • Revenue Growth
  • VIR N/A
  • DAKT N/A
  • 52 Week Low
  • VIR $4.32
  • DAKT $10.24
  • 52 Week High
  • VIR $14.45
  • DAKT $19.89
  • Technical
  • Relative Strength Index (RSI)
  • VIR 50.23
  • DAKT 50.97
  • Support Level
  • VIR $5.02
  • DAKT $13.60
  • Resistance Level
  • VIR $5.34
  • DAKT $14.40
  • Average True Range (ATR)
  • VIR 0.25
  • DAKT 0.49
  • MACD
  • VIR 0.03
  • DAKT -0.06
  • Stochastic Oscillator
  • VIR 47.53
  • DAKT 67.82

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

About DAKT Daktronics Inc.

Daktronics Inc designs and manufactures electronic scoreboards, programmable display systems, and large-screen video displays for sporting, commercial, and transportation applications. It is engaged in a full range of activities: marketing and sales, engineering and product design and development, manufacturing, technical contracting, professional services, and customer service and support. The company offers a complete line of products, from small scoreboards and electronic displays to large multimillion-dollar video display systems as well as related control, timing, and sound systems. The company has five reportable segments: Commercial, Live Events, High School Park and Recreation, Transportation, and International. The company makes the majority of its revenue from Live events.

Share on Social Networks: